Connor Clark & Lunn Investment Management Ltd. Raises Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Connor Clark & Lunn Investment Management Ltd. increased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 124.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 42,527 shares of the company's stock after purchasing an additional 23,553 shares during the period. Connor Clark & Lunn Investment Management Ltd.'s holdings in HCA Healthcare were worth $17,284,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Terra Nova Asset Management LLC increased its position in HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company's stock valued at $3,297,000 after buying an additional 26 shares in the last quarter. Massmutual Trust Co. FSB ADV boosted its holdings in HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company's stock worth $171,000 after purchasing an additional 29 shares during the last quarter. Waldron Private Wealth LLC increased its position in HCA Healthcare by 1.8% during the third quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company's stock valued at $683,000 after acquiring an additional 29 shares during the last quarter. Brookstone Capital Management lifted its stake in shares of HCA Healthcare by 0.7% in the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company's stock worth $1,652,000 after purchasing an additional 30 shares during the period. Finally, UMB Bank n.a. raised its position in HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company's stock worth $529,000 after acquiring an additional 30 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on HCA. Wells Fargo & Company lifted their price objective on HCA Healthcare from $395.00 to $400.00 and gave the company an "equal weight" rating in a research report on Wednesday, November 6th. Oppenheimer upped their price objective on HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a report on Monday, October 28th. Royal Bank of Canada upped their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an "outperform" rating in a research report on Friday, August 23rd. Barclays lowered their target price on shares of HCA Healthcare from $396.00 to $392.00 and set an "overweight" rating for the company in a report on Friday, November 8th. Finally, KeyCorp dropped their price objective on HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating for the company in a report on Monday, October 28th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $385.00.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the company's stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company's stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 15,155 shares of company stock worth $5,608,990. Insiders own 1.70% of the company's stock.

HCA Healthcare Trading Down 0.6 %

NYSE HCA opened at $333.00 on Thursday. The company has a 50 day moving average price of $381.99 and a 200 day moving average price of $358.12. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a 52 week low of $245.84 and a 52 week high of $417.14. The firm has a market cap of $84.35 billion, a PE ratio of 14.95, a price-to-earnings-growth ratio of 1.32 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date is Friday, December 13th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.